338 filings
Page 4 of 17
8-K
mlaqikk5v ped4
9 Dec 21
Pacira BioSciences Announces Closing of $375 Million Five-Year Term Loan B
8:15am
8-K
yif0nl5k jgi7u
7 Dec 21
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL® and iovera° of $48.0 Million for November 2021
8:02am
8-K
squ mecp9esrebo
19 Nov 21
Pacira BioSciences Completes Acquisition of Flexion Therapeutics and Strengthens Leadership Position in Non-Opioid Pain Management
9:17am
SC TO-T/A
05vunt4w
19 Nov 21
Third party tender offer statement (amended)
9:01am
SC TO-T/A
l6fdzz7pich4
18 Nov 21
Third party tender offer statement (amended)
6:02am
SC TO-T/A
but9lsp4rk6l4f9vi
12 Nov 21
Third party tender offer statement (amended)
6:05am
8-K
565 ohu3lgmnsix
9 Nov 21
Pacira BioSciences Reports Preliminary Net Product Sales of $44.3 Million for October 2021
8:01am
8-K
vtalt1yfjt55d1poml
3 Nov 21
Pacira BioSciences Reports Third Quarter 2021 Financial Results
8:04am
SC TO-T/A
kjf827nd
1 Nov 21
Third party tender offer statement (amended)
4:46pm
SC TO-T
z7jsjeig9n2y984
22 Oct 21
Third party tender offer statement
6:03am
SC TO-C
0zg2lt
12 Oct 21
Information about tender offer
6:08am
8-K
2v35omc
12 Oct 21
Pacira BioSciences to Acquire Flexion Therapeutics Further Expanding Leadership Position in Non-Opioid Pain Management
6:06am
8-K
ka6md5
15 Sep 21
Pacira BioSciences Reports Preliminary Net Product Sales of $42.3 Million for August 2021
7:31am
8-K
yhz60ac2u wf
10 Aug 21
Pacira BioSciences Reports Preliminary Net Product Sales of $42.1 Million for July 2021
8:02am
S-8
unn4kgc
3 Aug 21
Registration of securities for employees
4:31pm
8-K
tpujhby
3 Aug 21
Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021
8:02am
8-K
vm1wrwjrboohxs1r ur
13 Jul 21
Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021
8:02am
8-K
qmiq4 3d7
17 Jun 21
Departure of Directors or Certain Officers
4:30pm